ABOMICS
LIVE

Serial Number

79341934

Owner

Abomics Oy

Attorney

Lisa C. Pavento

Filing Date

Apr 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ABOMICS Trademark

Serial Number: 79341934 • Registration: 7292267

ABOMICS is a trademark filed by Abomics Oy on April 27, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Abomics Oy

Tykistökatu 4 B

Entity Type: 99

Trademark Details

Filing Date

April 27, 2022

Registration Date

January 30, 2024

Published for Opposition

November 14, 2023

Goods & Services

Downloadable computer software for access, viewing, recording, transmitting, processing, and visualization of medical data, pharmacogenetic data, and medicine data; Downloadable electronic databases containing structured medical data, pharmacogenetic data and medicine data, for use with computer software; Downloadable computer software for authorizing access to databases in the fields of pharmacogenetics and pharmaceuticals; Downloadable electronic databases featuring medical data in the field of pharmacogenetics, for use with computer software; Downloadable electronic databases featuring medical data in the field of pharmaceuticals, for use with computer software; Downloadable computer software and applications for access, viewing, recording, transmitting, and visualization of medical data, pharmacogenetic data and medicine data for use on mobile devices

Providing online medical record analysis services designed to provide patients and medical professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms other than in the field of dentistry; Providing online medical record analysis services designed to provide patients and medical professionals online clinical reports with information about medical conditions other than in the field of dentistry; Pharmaceutical advice, namely, providing online pharmacogenetic reports other than in the field of dentistry; Pharmaceutical advice; pharmaceutical advice, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical assistance; genetic testing for medical purposes; medical evaluation services for assessing effects and effectiveness of medical substances; Medical evaluation services for interpreting genes of patients to predict which drugs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment choices for patients, identify potentially harmful drug reactions and calculate drug dosage adjustments for patients; medical counselling; medical information; medical analysis services relating to treatment of patients; DNA screening for medical purposes; providing information relating to medical services; medical analysis for the diagnosis and treatment of persons; medical and healthcare services related to DNA, genetics and genetic testing; medical and healthcare services related to DNA, genetics and genetic testing, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical-gene interactions

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 21, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 30, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 30, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 30, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 30, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 27, 2023 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Nov 12, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 8, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 8, 2023 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 25, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 25, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 12, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 10, 2023 XAEC
EXAMINERS AMENDMENT -WRITTEN
Oct 10, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2023 TROA
REFUSAL PROCESSED BY IB
Apr 24, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 4, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 16, 2023 RFCR
NON-FINAL ACTION WRITTEN
Feb 15, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 15, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 21, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 10, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 2, 2022 SDRC